Miller F C, Nochimson D J, Paul R H, Hon E H
Obstet Gynecol. 1976 Jan;47(1):50-5.
The effects of ritodrine hydrochloride were evaluated in 25 toxemic patients in active labor utilizing continuous electronic monitoring of fetal and maternal cardiovascular systems and uterine activity. Fetal scalp blood and free flowing maternal antecubital venous blood was obtained for pH, Po2, Pco2, base deficit and blood glucose determinations prior to and immediately following the study period. The initial ritodrine dose was 50 mug/min for 15 minutes. The dose was increased by 50 mug/min each 15 minutes until there was a clinically apparent reduction in uterine activity. Once this was accomplished, the infusion was maintained for 30 minutes. There was a consistent increase in the maternal heart rate (MHR) and a significant rise in fetal heart rate (FHR) late in the infusion and in the postinfusion period. There was a widening of the maternal pulse pressure mainly due to a reduction in diastolic pressure with little change in the mean blood pressure. Maternal and fetal pH decreased and base deficit increased during the study although the PO2 and PCO2 remained unchanged. Maternal and fetal blood glucose rose significantly following ritodrine infusion.
利用胎儿和母体心血管系统及子宫活动的连续电子监测,对25例处于活跃期的子痫患者进行了盐酸利托君效果评估。在研究期之前及之后,采集胎儿头皮血和母体肘前静脉自由流动的血液,用于测定pH值、氧分压、二氧化碳分压、碱缺失和血糖。初始利托君剂量为50微克/分钟,持续15分钟。每15分钟将剂量增加50微克/分钟,直至子宫活动出现临床上明显的减弱。一旦达到这一效果,输注维持30分钟。输注后期及输注后母体心率(MHR)持续增加,胎儿心率(FHR)显著上升。母体脉压增宽,主要是由于舒张压降低,平均血压变化不大。研究期间母体和胎儿pH值下降,碱缺失增加,尽管氧分压和二氧化碳分压保持不变。利托君输注后母体和胎儿血糖显著升高。